000 04439nam a22003975i 4500
999 _c392334
_d392334
001 392334
003 ES-MaUEC
005 20230908104033.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 130413s2013 xxu| o |||| 0|eng d
020 _a9781627034050
024 7 _a10.1007/978-1-62703-405-0
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aQP101
_b2013 EB
245 0 0 _aVascular Proteomics :
_bMethods and Protocols
_cedited by Fernando Vivanco
250 _a1st edition 2013
264 1 _aTotowa, NJ
_bHumana Press
_c2013
300 _a1 recurso en línea (XI, 230 páginas)
_b43 ilustraciones, 33 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aMethods in Molecular Biology
_x1940-6029
_v1000
505 0 _aVascular Proteomics -- Laser Microdissection and Saturation Labeling Dige Method for the Analysis of Human Arteries -- Use of TOF-SIMS in Vascular Biology -- Proteomic Analysis of Vascular Smooth Muscle Cells with S- and R-Enantiomers of Atenolol by ITRAQ and LC-MS/MS -- Phosphoproteomic Analysis of Aortic Endothelial Cells Activated by Oxidized Phospholipids -- Characterization of Membrane and Cytosolic Proteins of Erythrocytes -- Characterization and Analysis of Human Arterial Tissue Secretome by 2-DE and NLC-MS/MS -- Identification of Novel Biomarkers of Abdominal Aortic Aneurysms (AAA) by 2D-DIGE and MALDI-MS FROM AAA-Thrombus Conditioned Media -- Metabolites Secreted by Human Atherothrombotic Aneurysm -- Quantitative Analysis of Apolipoproteins in Human HDL by Top-Down Differential Mass Spectrometry -- Quantitative Proteomics Analysis of High-Density Lipoproteins by Stable 18O-Isotope Labeling -- Unraveling Biomarkers of Abdominal Aortic Aneurisms by iTRAQ Analysis of Depleted Plasma -- Absolute Quantitation of Proteins in Human Blood by Multiplexed Multiple Reaction Monitoring Mass Spectrometry -- Multiple Reaction Monitoring (MRM) of Plasma Proteins in Cardiovascular Proteomics -- Proteomic Analysis of Plasma of Patients with Left Ventricular Remodeling After Myocardial Infarction. Usefulness of SELDI-TOF -- Proteomic Analysis of Urinary Exosomes in Cardiovascular and Associated Kidney Diseases by Two Dimensional Electrophoresis and LC-MS/MS.
520 _aProteomics is a rapidly expanding investigation platform in cardiovascular medicine. Driven by major improvements in mass spectrometry (MS) instrumentation and data analysis, the proteomics field has flourished in recent years particularly in the study of complex diseases. These recent advances are characterized by the development of quantitative MS-based methods that promoted the field from primarily identifying proteins to also providing measurements of relative changes in protein levels between different cell states. This progress is reflected in the application of proteomic techniques to vascular pathology. Vascular Proteomics: Methods and Protocols provides up-to-date methods and protocols for the analysis of arteries, cells, lipoproteins, body fluids, and metabolites, with a particular focus on MS-based methods of protein and peptide quantification. Written in the successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and notes on troubleshooting and avoiding known pitfalls.   Authoritative and easily accessible, Vascular Proteomics: Methods and Protocols is a representative selection of methods that can be a useful resource for experienced proteomics practitioners as well as newcomers interested in becoming acquainted with the practice of proteomic techniques for cardiovascular research.
988 _aSpringer_Protocols_2013
650 7 _2embne
_9138556
_aAparato circulatorio
_vManuales de laboratorio
776 0 8 _iPrinted edition:
_z9781627034067
776 0 8 _iPrinted edition:
_z9781627034043
776 0 8 _iPrinted edition:
_z9781493960019
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-62703-405-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b09/2023
_dz
_eu
_zSI